Endocrine Therapy of Breast Cancer V /
This is the fifth issue of the monograph on Endocrine Therapy of Breast Cancer. The spectrum of the items is remarkably broad and includes the normal breast cell, the cancer cell, mechanisms of resistance to therapeuticagents, new endocrine treatments, the patient with breast cancer, her quality of...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
1992.
|
| Series: | ESO Monographs, European School of Oncology.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Introduction
- Normal Cell Lineages and the Phenotype of the Breast Cancer Cell
- The Oestrogen-Related pS2-BCEI Protein in Breast Cancer
- Do All Roads Lead to the Oestrogen Receptor?- Tamoxifen for the Treatment of Breast Cancer in the Premenopausal Patient
- The Multi-Drug Resistance Phenotype and its Reversal by Drugs (with Special Emphasis on Anti- Oestrogens)
- New Endocrine Agents for Breast Cancer
- Prognostic Factors in Primary Breast Cancer: Second Thoughts
- The Contribution of Perturbed Epithelial-Mesenchymal Interactions to Cancer Pathogenesis
- Reporting Results from Adjuvant Therapy Trials with Special Emphasis on Quality-of-Life Findings
- Adjuvant Chemoendocrine Therapies in Pre- and Post-Menopausal Breast Cancer.